| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Radiation Oncology, New England Medical Center [X-L. L., D. E. W., K. W., V. B.], and Department of Biochemistry, Tufts University School of Medicine [V. B.], Boston, Massachusetts 02111
In an effort to isolate genes with down-regulated expression at the mRNA level during oncogenic transformation of human mammary epithelial cells (MECs), we performed subtractive hybridization between normal MEC strain 76N and its radiation-transformed tumorigenic derivative 76R-30. Here, we report the isolation of cDNA clones corresponding to a 1.4-kb mRNA species that is abundantly expressed in 76N cells but is drastically reduced in 76R-30 cells. Based on its selective expression in MECs compared with fibroblasts, the corresponding gene is designated NES1 (normal epithelial cell-specific 1). Sequence analysis of the full-length NES1 cDNA clones revealed it to be a novel gene with a predicted polypeptide of 30.14 kilodaltons; in vitro transcription and translation confirmed this prediction. Database searches revealed a 50–63% similarity and 34–42% identity with several families of serine proteases, in particular the trypsin-like proteases, members of the glandular kallikrein family (including prostate-specific antigen, nerve growth factor 
, and epidermal growth factor-binding protein) and the activators for the kringle family proteins (including the human tissue plasminogen activator and human hepatocyte growth factor activator). Importantly, all of the residues known to be crucial for substrate binding, specificity, and catalysis by the serine proteases are conserved in the predicted NES1 protein, suggesting that it may be a protease. An antipeptide antibody directed against a unique region of the NES1 protein (amino acids 120–137) detected a specific 30-kilodalton polypeptide almost exclusively in the supernatant of the mRNA-positive MECs, suggesting that NES1 is a secreted protein. The 1.4-kb NES1 mRNA was expressed in several organs (thymus, prostate, testis, ovary, small intestine, colon, heart, lung, and pancreas) with highest levels in the ovary; a 1.1-kb transcript was found in the pancreas. Although expression of the NES1 mRNA was observed in all normal and immortalized nontumorigenic MECs, the majority of human breast cancer cell lines showed a drastic reduction or a complete lack of its expression. The structural similarity of NES1 to polypeptides known to regulate growth factor activity and a negative correlation of NES1 expression with breast oncogenesis suggest a direct or indirect role for this novel protease-like gene product in the suppression of tumorigenesis.
1 This work was supported by departmental start-up funds (V. B.).
2 To whom requests for reprints should be addressed, at Department of Biochemistry, Tufts University School of Medicine, 750 Washington Street, Boston, MA 02111. Phone: (617) 636-4776; Fax: (617) 636-6205.
Received 3/ 7/96. Accepted 5/16/96.
This article has been cited by other articles:
|
|
 |
|
  C. Planque, L. Li, Y. Zheng, A. Soosaipillai, K. Reckamp, D. Chia, E. P. Diamandis, and L. Goodglick A Multiparametric Serum Kallikrein Panel for Diagnosis of Non-Small Cell Lung Carcinoma Clin. Cancer Res., March 1, 2008; 14(5): 1355 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L.V. Shaw and E. P. Diamandis Distribution of 15 Human Kallikreins in Tissues and Biological Fluids Clin. Chem., August 1, 2007; 53(8): 1423 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dorn, M. Schmitt, R. Kates, B. Schmalfeldt, M. Kiechle, A. Scorilas, E. P. Diamandis, and N. Harbeck Primary Tumor Levels of Human Tissue Kallikreins Affect Surgical Success and Survival in Ovarian Cancer Patients Clin. Cancer Res., March 15, 2007; 13(6): 1742 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Debela, V. Magdolen, N. Schechter, M. Valachova, F. Lottspeich, C. S. Craik, Y. Choe, W. Bode, and P. Goettig Specificity Profiling of Seven Human Tissue Kallikreins Reveals Individual Subsite Preferences J. Biol. Chem., September 1, 2006; 281(35): 25678 - 25688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Borgono, I. P. Michael, and E. P. Diamandis Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer Mol. Cancer Res., May 1, 2004; 2(5): 257 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Yousef, M.-E. Polymeris, L. Grass, A. Soosaipillai, P.-C. Chan, A. Scorilas, C. Borgono, N. Harbeck, B. Schmalfeldt, J. Dorn, et al. Human Kallikrein 5: A Potential Novel Serum Biomarker for Breast and Ovarian Cancer Cancer Res., July 15, 2003; 63(14): 3958 - 3965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. TURECI, J. DING, H. HILTON, H. BIAN, H. OHKAWA, M. BRAXENTHALER, G. SEITZ, L. RADDRIZZANI, H. FRIESS, M. BUCHLER, et al. Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles FASEB J, March 1, 2003; 17(3): 376 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-Y. Luo, D. Katsaros, A. Scorilas, S. Fracchioli, R. Bellino, M. van Gramberen, H. de Bruijn, A. Henrik, U.-H. Stenman, M. Massobrio, et al. The Serum Concentration of Human Kallikrein 10 Represents a Novel Biomarker for Ovarian Cancer Diagnosis and Prognosis Cancer Res., February 15, 2003; 63(4): 807 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Petraki, V. N. Karavana, L.-Y. Luo, and E. P. Diamandis Human Kallikrein 10 Expression in Normal Tissues by Immunohistochemistry J. Histochem. Cytochem., September 1, 2002; 50(9): 1247 - 1261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kumar, Y. Zhao, G. Meng, M. Zeng, S. Srinivasan, L. M. Delmolino, Q. Gao, G. Dimri, G. F. Weber, D. E. Wazer, et al. Human Papillomavirus Oncoprotein E6 Inactivates the Transcriptional Coactivator Human ADA3 Mol. Cell. Biol., August 15, 2002; 22(16): 5801 - 5812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Diamandis and G. M. Yousef Human Tissue Kallikreins: A Family of New Cancer Biomarkers Clin. Chem., August 1, 2002; 48(8): 1198 - 1205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. X. Gomis-Ruth, A. Bayes, G. Sotiropoulou, G. Pampalakis, T. Tsetsenis, V. Villegas, F. X. Aviles, and M. Coll The Structure of Human Prokallikrein 6 Reveals a Novel Activation Mechanism for the Kallikrein Family J. Biol. Chem., July 19, 2002; 277(30): 27273 - 27281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Petraki, V. N. Karavana, P. T. Skoufogiannis, S. P. Little, D. J.C. Howarth, G. M. Yousef, and E. P. Diamandis The Spectrum of Human Kallikrein 6 (Zyme/Protease M/Neurosin) Expression in Human Tissues as Assessed by Immunohistochemistry J. Histochem. Cytochem., November 1, 2001; 49(11): 1431 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Yousef, L. G. Kyriakopoulou, A. Scorilas, S. Fracchioli, B. Ghiringhello, M. Zarghooni, A. Chang, M. Diamandis, G. Giardina, W. J. Hartwick, et al. Quantitative Expression of the Human Kallikrein Gene 9 (KLK9) in Ovarian Cancer: A New Independent and Favorable Prognostic Marker Cancer Res., November 1, 2001; 61(21): 7811 - 7818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Li, J. Goyal, S. Dhar, G. Dimri, E. Evron, S. Sukumar, D. E. Wazer, and V. Band CpG Methylation as a Basis for Breast Tumor-specific Loss of NES1/Kallikrein 10 Expression Cancer Res., November 1, 2001; 61(21): 8014 - 8021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dhar, R. Bhargava, M. Yunes, B. Li, J. Goyal, S. P. Naber, D. E. Wazer, and V. Band Analysis of Normal Epithelial Cell Specific-1 (NES1)/Kallikrein 10 mRNA Expression by in Situ Hybridization, a Novel Marker for Breast Cancer Clin. Cancer Res., November 1, 2001; 7(11): 3393 - 3398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-Y. Luo, D. Katsaros, A. Scorilas, S. Fracchioli, R. Piccinno, I. A. Rigault de la Longrais, D. J. C. Howarth, and E. P. Diamandis Prognostic Value of Human Kallikrein 10 Expression in Epithelial Ovarian Carcinoma Clin. Cancer Res., August 1, 2001; 7(8): 2372 - 2379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Yousef and E. P. Diamandis The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease Endocr. Rev., April 1, 2001; 22(2): 184 - 204. [Abstract] [Full Text]
|
|
|
|
|
|
G. M. Yousef, A. Magklara, A. Chang, K. Jung, D. Katsaros, and E. P. Diamandis Cloning of a New Member of the Human Kallikrein Gene Family, KLK14, Which Is Down-Regulated in Different Malignancies Cancer Res., April 1, 2001; 61(8): 3425 - 3431. [Abstract] [Full Text]
|
|
|
|
|
|
L.-Y. Luo, L. Grass, D. J.C. Howarth, P. Thibault, H. Ong, and E. P. Diamandis Immunofluorometric Assay of Human Kallikrein 10 and Its Identification in Biological Fluids and Tissues Clin. Chem., February 1, 2001; 47(2): 237 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Diamandis, G. M. Yousef, J. Clements, L. K. Ashworth, S. Yoshida, T. Egelrud, P. S. Nelson, S. Shiosaka, S. Little, H. Lilja, et al. New Nomenclature for the Human Tissue Kallikrein Gene Family Clin. Chem., November 1, 2000; 46(11): 1855 - 1858. [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Hennebold, M. Tanaka, J. Saito, B. R. Hanson, and E. Y. Adashi Ovary-Selective Genes I: The Generation and Characterization of an Ovary-Selective Complementary Deoxyribonucleic Acid Library Endocrinology, August 1, 2000; 141(8): 2725 - 2734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Diamandis Prostate-specific Antigen: A Cancer Fighter and a Valuable Messenger? Clin. Chem., July 1, 2000; 46(7): 896 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Yousef, A. Chang, and E. P. Diamandis Identification and Characterization of KLK-L4, a New Kallikrein-like Gene That Appears to be Down-regulated in Breast Cancer Tissues J. Biol. Chem., April 14, 2000; 275(16): 11891 - 11898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Yousef and E. P. Diamandis The New Kallikrein-like Gene, KLK-L2. MOLECULAR CHARACTERIZATION, MAPPING, TISSUE EXPRESSION, AND HORMONAL REGULATION J. Biol. Chem., December 31, 1999; 274(53): 37511 - 37516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Yousef, C. V. Obiezu, L.-Y. Luo, M. H. Black, and E. P. Diamandis Prostase/KLK-L1 Is a New Member of the Human Kallikrein Gene Family, Is Expressed in Prostate and Breast Tissues, and Is Hormonally Regulated Cancer Res., September 1, 1999; 59(17): 4252 - 4256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-A. Stephenson, K. Verity, L. K. Ashworth, and J. A. Clements Localization of a New Prostate-specific Antigen-related Serine Protease Gene, KLK4, Is Evidence for an Expanded Human Kallikrein Gene Family Cluster on Chromosome 19q13.3-13.4 J. Biol. Chem., August 13, 1999; 274(33): 23210 - 23214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Hooper, D. L. Nicol, J. L. Dickinson, H. J. Eyre, A. L. Scarman, J. F. Normyle, M. A. Stuttgen, M. L. Douglas, K. A. Lakoski Loveland, G. R. Sutherland, et al. Testisin, a New Human Serine Proteinase Expressed by Premeiotic Testicular Germ Cells and Lost in Testicular Germ Cell Tumors Cancer Res., July 1, 1999; 59(13): 3199 - 3205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lopez-Otin and E. P. Diamandis Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features Endocr. Rev., August 1, 1998; 19(4): 365 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Harvey, J. D. Hooper, S. A. Myers, S.-A. Stephenson, L. K. Ashworth, and J. A. Clements Tissue-specific Expression Patterns and Fine Mapping of the Human Kallikrein (KLK) Locus on Proximal 19q13.4 J. Biol. Chem., November 22, 2000; 275(48): 37397 - 37406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Yousef, A. Scorilas, K. Jung, L. K. Ashworth, and E. P. Diamandis Molecular Cloning of the Human Kallikrein 15 Gene (KLK15). UP-REGULATION IN PROSTATE CANCER J. Biol. Chem., January 5, 2001; 276(1): 53 - 61. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
